Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Drug repurposing for COVID-19 using computational screening: Is Fostamatinib/R406 a potential candidate?

26 Aug 2021

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Computational Drug Discovery Methods
Share to SARS-CoV-2 and COVID-19 Research
Share to vaccines and immunoinformatics approaches

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 34455072
DOI: 10.1016/j.ymeth.2021.08.007

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Drug repurposing for COVID-19 using computational screening: Is Fostamatinib/R406 a potential candidate?PMID 34455072Read ↗

Drug-repurposing against COVID-19 by targeting a key signaling pathway: An in silico studySemantic proximity Read ↗

Drug repurposing for SARS-CoV-2: a high-throughput molecular docking, molecular dynamics, machine learning, and DFT studySemantic proximity Read ↗

Integrated Docking and Enhanced Sampling Based Selection of Repurposing Drugs for SARS-CoV-2 by Targeting Host Dependent FactorsSemantic proximity Read ↗

Recognition of plausible therapeutic agents to combat COVID-19: An omics data based combined approachSemantic proximity Read ↗

Translating GWAS Findings to Inform Drug Repositioning Strategies for COVID-19 TreatmentSemantic proximity Read ↗

Drug Repurposing of potential drug targets for treatment of COVID-19Semantic proximity Read ↗

A Comprehensive Review of Drug Repurposing Strategies against Known Drug Targets of COVID-19Semantic proximity Read ↗

In Silico Evaluation of Prospective Anti-COVID-19 Drug Candidates as Potential SARS-CoV-2 Main Protease InhibitorsSemantic proximity Read ↗

Dual computational and biological assessment of some promising nucleoside analogs against the COVID-19-Omicron variantSemantic proximity Read ↗

Identification of drugs targeting multiple viral and human proteins using computational analysis for repurposing against COVID-19Semantic proximity Read ↗

Genomics insights of SARS-CoV-2 (COVID-19) into target-based drug discoverySemantic proximity Read ↗

Systematic Down-Selection of Repurposed Drug Candidates for COVID-19Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.